{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:42:51Z","timestamp":1762004571218,"version":"3.40.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2334-13-603","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T06:00:59Z","timestamp":1388037659000},"source":"Crossref","is-referenced-by-count":12,"title":["Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012"],"prefix":"10.1186","volume":"13","author":[{"given":"Helen","family":"Kovari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria DG","family":"de Melo Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Hauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Severin","family":"L\u00e4uchli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrg","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Zbinden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,26]]},"reference":[{"key":"2952_CR1","volume-title":"Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases","author":"JM Marrazzo","year":"2010","unstructured":"Marrazzo JM, Handsfield HH, Sparling PF: Neisseria gonorrhoeae. Mandell, Douglas, and Bennett\u2019s Principles and Practice of Infectious Diseases. Edited by: Mandell GL, Bennett JE, Dolin R. 2010, Philadelphia: Churchill Livingstone Elsevier, 7","edition":"7"},{"issue":"1","key":"2952_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/sti.75.1.3","volume":"75","author":"DT Fleming","year":"1999","unstructured":"Fleming DT, Wasserheit JN: From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999, 75 (1): 3-17. 10.1136\/sti.75.1.3.","journal-title":"Sex Transm Infect"},{"issue":"10","key":"2952_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1517\/14656566.2012.690396","volume":"13","author":"JE Stoltey","year":"2012","unstructured":"Stoltey JE, Barry PM: The use of cephalosporins for gonorrhea: an update on the rising problem of resistance. Expert Opin Pharmacother. 2012, 13 (10): 1411-1420. 10.1517\/14656566.2012.690396.","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"2952_CR4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3201\/eid1308.060948","volume":"13","author":"S Yokoi","year":"2007","unstructured":"Yokoi S, Deguchi T, Ozawa T, Yasuda M, Ito S, Kubota Y, Tamaki M, Maeda S: Threat to cefixime treatment for gonorrhea. Emerg Infect Dis. 2007, 13 (8): 1275-1277.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"2952_CR5","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1128\/AAC.00198-08","volume":"52","author":"JY Lo","year":"2008","unstructured":"Lo JY, Ho KM, Leung AO, Tiu FS, Tsang GK, Lo AC, Tapsall JW: Ceftibuten resistance and treatment failure of Neisseria gonorrhoeae infection. Antimicrob Agents Chemother. 2008, 52 (10): 3564-3567. 10.1128\/AAC.00198-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"2952_CR6","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H: Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 2010, 15 (47):","DOI":"10.2807\/ese.15.47.19721-en"},{"key":"2952_CR7","doi-asserted-by":"crossref","unstructured":"Ison CA, Hussey J, Sankar KN, Evans J, Alexander S: Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill. 2011, 16 (14):","DOI":"10.2807\/ese.16.14.19833-en"},{"key":"2952_CR8","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Stary A, Eigentler A: First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill. 2011, 16 (43):","DOI":"10.2807\/ese.16.43.19998-en"},{"issue":"2","key":"2952_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1001\/jama.2012.176575","volume":"309","author":"VG Allen","year":"2013","unstructured":"Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, Siebert H, Towns L, Melano RG, Low DE: Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA. 2013, 309 (2): 163-170. 10.1001\/jama.2012.176575.","journal-title":"JAMA"},{"issue":"6","key":"2952_CR10","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/jac\/dkt034","volume":"68","author":"DA Lewis","year":"2013","unstructured":"Lewis DA, Sriruttan C, Muller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M: Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother. 2013, 68 (6): 1267-1270. 10.1093\/jac\/dkt034.","journal-title":"J Antimicrob Chemother"},{"issue":"Pt 5","key":"2952_CR11","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1099\/jmm.0.007641-0","volume":"58","author":"J Tapsall","year":"2009","unstructured":"Tapsall J, Read P, Carmody C, Bourne C, Ray S, Limnios A, Sloots T, Whiley D: Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol. 2009, 58 (Pt 5): 683-687.","journal-title":"J Med Microbiol"},{"key":"2952_CR12","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Hestner A: Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, 2010. Euro Surveill. 2011, 16 (6):","DOI":"10.2807\/ese.16.06.19792-en"},{"issue":"7","key":"2952_CR13","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M: Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011, 55 (7): 3538-3545. 10.1128\/AAC.00325-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2952_CR14","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P: High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012, 56 (3): 1273-1280. 10.1128\/AAC.05760-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"2952_CR15","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1093\/jac\/dks162","volume":"67","author":"J Camara","year":"2012","unstructured":"Camara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C: Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother. 2012, 67 (8): 1858-1860. 10.1093\/jac\/dks162.","journal-title":"J Antimicrob Chemother"},{"key":"2952_CR16","doi-asserted-by":"crossref","unstructured":"Unemo M: The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy. Euro Surveill. 2012, 17 (47):","DOI":"10.2807\/ese.17.47.20323-en"},{"key":"2952_CR17","doi-asserted-by":"crossref","unstructured":"Update to CDC\u2019s Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. MMWR Morb Mortal Wkly Rep. 2012, 61 (31): 590-594.","DOI":"10.1016\/j.annemergmed.2012.10.014"},{"key":"2952_CR18","unstructured":"Bundesamt f\u00fcr Gesundheit. 2013, http:\/\/www.bag.admin.ch\/k_m_meldesystem\/00733\/00813\/index.html?lang=de . Accessed May 4, 2013"},{"issue":"15\u201316","key":"2952_CR19","first-page":"243","volume":"138","author":"B Le Lin","year":"2008","unstructured":"Le Lin B, Pastore R, Liassine N, Aramburu C, Sudre P: A new sexually transmitted infection (STI) in Geneva? Ciprofloxacin-resistant Neisseria gonorrhoeae, 2002\u20132005. Swiss Med Wkly. 2008, 138 (15\u201316): 243-246.","journal-title":"Swiss Med Wkly"},{"key":"2952_CR20","unstructured":"World Health Organization (WHO): Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. http:\/\/whqlibdoc.who.int\/publications\/2012\/9789241503501_eng.pdf ,"},{"key":"2952_CR21","unstructured":"Breakpoint tablets for interpretation of MICs and zone diameters: version 3.1. European Committee on Antimicrobial Susceptibility Testing. http:\/\/www.eucast.org\/clinical_breakpoints\/ . Accessed April 30"},{"key":"2952_CR22","unstructured":"Gonococcal antimicrobial susceptibility surveillance in Europe 2010 Stockholm: ECDC 2012:European Centre for Disease Prevention and Control (ECDC). 2010, Available from: http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/1206-Gonococcal-AMR.pdf , Stockholm: ECDC 2012:European Centre for Disease Prevention and Control (ECDC),"},{"key":"2952_CR23","unstructured":"CDC Grand rounds: the growing threat of multidrug-resistant gonorrhea. MMWR Morb Mortal Wkly Rep. 2013, 62 (6): 103-106."},{"issue":"9372","key":"2952_CR24","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/S0140-6736(03)13489-7","volume":"361","author":"KA Fenton","year":"2003","unstructured":"Fenton KA, Ison C, Johnson AP, Rudd E, Soltani M, Martin I, Nichols T, Livermore DM: Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet. 2003, 361 (9372): 1867-1869. 10.1016\/S0140-6736(03)13489-7.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"2952_CR25","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.ijantimicag.2004.02.005","volume":"24","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Nakayama H, Notomi T, Irie S, Tsunoda Y, Okadome A, Saika T, Kobayashi I: Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993\u20132002: continuous increasing of ciprofloxacin-resistant isolates. Int J Antimicrob Agents. 2004, 24 (Suppl 1): S15-22.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"2952_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1086\/426142","volume":"40","author":"PR Hsueh","year":"2005","unstructured":"Hsueh PR, Tseng SP, Teng LJ, Ho SW: High prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Northern Taiwan. Clin Infect Dis. 2005, 40 (1): 188-192. 10.1086\/426142.","journal-title":"Clin Infect Dis"},{"key":"2952_CR27","unstructured":"Update to CDC\u2019s sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007, 56 (14): 332-336."},{"issue":"1","key":"2952_CR28","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/jac\/dkm434","volume":"61","author":"JW Tapsall","year":"2008","unstructured":"Tapsall JW, Limnios EA, Murphy D: Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006. J Antimicrob Chemother. 2008, 61 (1): 150-155.","journal-title":"J Antimicrob Chemother"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-603.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-13-603\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-603","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-13-603.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T09:09:33Z","timestamp":1746090573000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-13-603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2952"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-13-603","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2013,12]]},"article-number":"603"}}